Related Experiment Video

Updated: Aug 11, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

Analysis of karyotype, SCE, and point mutation of RAS oncogene in Indian MDS patients

A M Mansoor1, T P Bharadwaj, S Sethuraman

  • 1Department of Hematology, Hiroshima University, Japan.

Cancer Genetics and Cytogenetics
|January 1, 1993
PubMed

Insights

This study investigated genetic changes in Indian patients with myelodysplastic syndromes (MDS). Karyotype abnormalities were found in 37.5% of patients, with no significant changes in sister chromatid exchange or RAS oncogene mutations.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
  • Understanding the genetic landscape of MDS is crucial for diagnosis and treatment.
  • Previous studies on genetic abnormalities in Indian MDS patients are limited.

Purpose of the Study:

  • To investigate the frequencies of nonrandom karyotype abnormalities.
  • To assess sister chromatid exchange (SCE) rates.
  • To identify point mutations in RAS oncogenes (NRAS and KRAS) in Indian patients with primary MDS.

Main Methods:

  • Karyotype analysis was performed on bone marrow cells of 24 patients.
  • Sister chromatid exchange (SCE) was studied in 6 MDS patients.
  • Point mutations in codons 12 and 61 of NRAS and KRAS genes were analyzed in 10 MDS patients.

Main Results:

  • Nonrandom karyotypic changes were observed in 9 out of 24 (37.5%) patients.
  • Commonly detected chromosomal anomalies involved chromosomes 5, 7, and 8.
  • Two novel anomalies, del(8)(q22) and +19, were identified.
  • Normal SCE incidence was noted.
  • One patient showed a base substitution in the KRAS gene.

Conclusions:

  • This study provides initial insights into the genetic alterations in primary MDS among Indian patients.
  • Karyotypic abnormalities are prevalent in this population.
  • Further research is warranted to elucidate the role of these genetic changes in MDS pathogenesis in India.

More Related Videos

Comparative Lesions Analysis Through a Targeted Sequencing Approach08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection05:42

Isolation of Cells with Morphological and Spatial Information from Oral Submucous Fibrosis Samples by Laser Capture Microdissection

Published on: August 11, 2023

Related Concept Videos

Karyotyping01:17

Karyotyping

Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...